The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction

被引:17
|
作者
Di Martino, Mirko [1 ]
Kirchmayer, Ursula [1 ]
Agabiti, Nera [1 ]
Bauleo, Lisa [1 ]
Fusco, Danilo [1 ]
Perucci, Carlo Alberto
Davoli, Marina [1 ]
机构
[1] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
来源
BMJ OPEN | 2015年 / 5卷 / 06期
关键词
MORTALITY;
D O I
10.1136/bmjopen-2015-007866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Time-window bias was described in case-control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. Setting: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). Participants: Patients discharged after MI in 2006-2007 were enrolled in the cohort and followed through 2009. Outcome measure: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. Design: A nested case-control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, a-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). Results: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and a-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for '0.5<PDC <= 0.75' and 'PDC>0.75' versus '0 <= PDC <= 0.5'. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. Conclusions: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Impact of diabetes on long-term survival after acute myocardial infarction - Comparability of risk with prior myocardial infarction
    Mukamal, KJ
    Nesto, RW
    Cohen, MC
    Muller, JE
    Maclure, M
    Sherwood, JB
    Mittleman, MA
    DIABETES CARE, 2001, 24 (08) : 1422 - 1427
  • [32] LONG-TERM PHARMACOLOGICAL PREVENTION OF HEART-FAILURE AFTER MYOCARDIAL-INFARCTION
    SHABETAI, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S64 - S67
  • [33] Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention
    Reuter, Hannes
    Markhof, Anne
    Scholz, Steffen
    Wegmann, Christian
    Seck, Catherine
    Adler, Christoph
    Michels, Guido
    Hoepp, Hans-Wilhelm
    Baldus, Stephan
    Pfister, Roman
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (07) : 890 - 898
  • [34] Effect of Adherence to Antihypertensive Medication on the Long-Term Outcome After Hemorrhagic Stroke in Korea
    Kim, Jinkwon
    Bushnell, Cheryl D.
    Lee, Hye Sun
    Han, Sang Won
    HYPERTENSION, 2018, 72 (02) : 391 - 398
  • [35] Changes in the use of medications after acute myocardial infarction:: possible impact on mortality after myocardial infarction and long-term outcome
    Herlitz, J
    Dellborg, R
    Karlson, BW
    Lindqvist, J
    Karlsson, T
    Sandén, W
    Sjölin, M
    Wedel, H
    CORONARY ARTERY DISEASE, 2001, 12 (01) : 61 - 67
  • [36] EFFECT ON SURVIVAL AFTER MYOCARDIAL-INFARCTION OF LONG-TERM TREATMENT WITH PHENYTOIN
    PETER, T
    ROSS, D
    DUFFIELD, A
    LUXTON, M
    HARPER, R
    HUNT, D
    SLOMAN, G
    BRITISH HEART JOURNAL, 1978, 40 (12): : 1356 - 1360
  • [38] EFFECT OF LONG-TERM PROPHYLACTIC TREATMENT ON SURVIVAL AFTER MYOCARDIAL-INFARCTION
    FURBERG, CD
    MAY, GS
    AMERICAN JOURNAL OF MEDICINE, 1984, 76 (6A): : 76 - 83
  • [39] The Impact of Periprocedural Myocardial Infarction on Long-Term Outcomes After Carotid Artery Stenting
    Metzger, Christopher
    Hibbard, Robert
    Massop, Douglas
    Shah, Rasesh
    Mann, Tift
    Ashchi, Majdi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B150 - B150
  • [40] Impact of sleep apnea on long-term prognosis in patients after acute myocardial infarction
    Ludka, O.
    Stepanova, R.
    Kara, T.
    Spinar, J.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 39 - 39